Watershed Informatics is a technology company.
Watershed Informatics has raised $15.0M across 1 funding round.
Watershed Informatics has raised $15.0M in total across 1 funding round.
Watershed Informatics has raised $15.0M in total across 1 funding round.
Watershed Informatics's investors include Canvas Ventures, Cyberstarts VC, FirstHand Alliance, Haun Ventures, New Form Capital, Pantera Capital, Pioneer Fund, The Hit Forge, Tioga Capital Partners, Balaji Srinivasan, Kevin Weil, Mike Giampapa.
Watershed Informatics is a bioinformatics technology company that builds Omics Bench, a cloud-based platform unifying multi-omics data analysis for biological research.[1][2][4] It serves life sciences researchers, biopharma discovery teams, biologists, and bioinformaticians by solving the fragmentation of tools for genomics, proteomics, transcriptomics, and more, enabling secure, scalable processing from sample to therapeutic insight in a single day with automation and collaboration features.[1][2][4] The platform has driven strong growth, processing 300TB of data monthly, reducing analysis time by 86%, and boosting productivity 10x, backed by a $14.5M Series A in 2023 from Canvas Ventures, Bessemer Venture Partners, and Accomplice.[1][2]
Watershed was co-founded in 2019 (with formal operations ramping in 2020) by MIT graduates Jonathan Wang (CEO) and Mark Kalinich, who identified a critical gap in handling exploding volumes of biological data amid fragmented tools.[1][2] Drawing from their expertise in high-performance computing, bioinformatics, and computational biology, they launched to create a centralized platform accessible to scientists regardless of coding skills.[2] Early traction built through solving real-world drug discovery pain points, leading to the 2023 Series A funding that accelerated product innovation and partnerships across industry and academia.[1][2]
Watershed rides the multi-omics revolution in precision medicine, where exponential growth in biological data (genomics, proteomics) outpaces fragmented, resource-intensive tools limited to top-funded labs.[1][2] Timing aligns with cloud computing maturity and AI-driven biology, enabling scalable insights that accelerate drug discovery pipelines amid rising biopharma demand for faster, collaborative R&D.[1][3][4] It influences the ecosystem by democratizing Bio-IT for hundreds of researchers, reducing barriers for academia and smaller biotechs, and partnering to scale breakthroughs in cancer research, therapeutics, and beyond.[2][4]
Watershed is primed to expand its platform with ongoing hires in engineering, bioinformatics, and marketing, leveraging Series A momentum to deepen biopharma integrations and workflow libraries.[2] Trends like AI-multi-omics fusion and high-throughput sequencing will amplify its edge, potentially capturing more of the $10B+ bioinformatics market as data volumes surge.[1][4] Its influence may evolve from niche enabler to ecosystem standard, transforming how medicines are discovered—starting from that 2019 insight into unified data power.
Watershed Informatics has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series A in March 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2023 | $15.0M Series A | Canvas Ventures, Cyberstarts VC, FirstHand Alliance, Haun Ventures, New Form Capital, Pantera Capital, Pioneer Fund, The Hit Forge, Tioga Capital Partners, Balaji Srinivasan, Kevin Weil, Mike Giampapa |